Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 6 of 6 for Age related macular degeneration 6
  1. ... system problems), glucose-6-phosphate dehydrogenase deficiency (G-6-PD; an inherited blood disease), or other blood disorders; dermatitis (skin inflammations); seizures; vision problems, including macular degeneration (an ongoing disease of the eye that causes ...
  2. ... products are used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that ... is also used to treat wet age-related macular degeneration after at least two successful treatments with ranibizumab ...
  3. ... injection is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that ... once a month for the first 4 or 6 doses, and then once every 1 to 4 ...
  4. ... injection is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that ... usually given in a doctor's office once every 6 weeks. Before you receive a pegaptanib injection, your ...
  5. ... to vision loss in older adults (age-related macular degeneration or AMD). Taking zinc by mouth, especially with ... not exceed 4 mg daily in infants 0-6 months old, 5 mg daily in infants 7- ...
  6. ... also sometimes used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that ... a bevacizumab injection product and for at least 6 months after your final dose. If you become ...